These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28752703)

  • 1. [Synthesis, characterization and antitumor activity of 5-fluorouracil-nicotinamide cocrystal].
    Min WU; Xingang L; Yu X; Qi C; Xiurong HU; Jun Z; Guping T
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):127-133. PubMed ID: 28752703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocrystallization of 5-fluorouracil with gallic acid: A novel 5-fluorouracil cocrystal displaying synergistic anti-tumor activity both in oral and intraperitoneal injection administration.
    Hao H; Zhang Y; Hu X; Guo W; Yang C; Wang J
    Eur J Pharm Biopharm; 2023 Jun; 187():12-23. PubMed ID: 37031731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility.
    Park B; Yoon W; Yun J; Ban E; Yun H; Kim A
    Int J Pharm; 2019 Feb; 557():26-35. PubMed ID: 30572078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novice cocrystal nanomicelle formulation of 5-fluorouracil with proline: The design, self-assembly and in vitro/vivo biopharmaceutical characteristics.
    Yu YM; Liu L; Bu FZ; Li YT; Yan CW; Wu ZY
    Int J Pharm; 2022 Apr; 617():121635. PubMed ID: 35257803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first marine dual-drug cocrystal of cytarabine with 5-fluorouracil having synergistic antitumor effects shows superior biopharmaceutical peculiarities by oral administration.
    Yu YM; Bu FZ; Meng SS; Yan CW; Wu ZY; Li YT
    Int J Pharm; 2022 Dec; 629():122386. PubMed ID: 36372139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters.
    Gautam MK; Besan M; Pandit D; Mandal S; Chadha R
    AAPS PharmSciTech; 2019 Mar; 20(4):149. PubMed ID: 30903402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
    Huang Y; Zhang B; Gao Y; Zhang J; Shi L
    J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Characterization, Theoretical and Experimental Anticancer Evaluation of Novel Cocrystals of 5-Fluorouracil and Schiff Bases against SW480 Colorectal Carcinoma.
    Jubeen F; Jabeen I; Aftab U; Noor S; Hareem ME; Sultan M; Kazi M
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations.
    Renkoğlu P; Çelebier M; Arıca-Yegin B
    Pharm Dev Technol; 2015 May; 20(3):380-4. PubMed ID: 24521464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First cocrystal of esculetin: Simultaneously optimized in vitro/vivo properties and antioxidant effect.
    Liu F; Li JY; Han CB; Wang JH; Tong SY; Wang XK; Li YT; Sun WJ
    Eur J Pharm Sci; 2023 Aug; 187():106469. PubMed ID: 37209999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization and structural evaluation of a specific 2:1 cocrystal of naproxen-nicotinamide.
    Ando S; Kikuchi J; Fujimura Y; Ida Y; Higashi K; Moribe K; Yamamoto K
    J Pharm Sci; 2012 Sep; 101(9):3214-21. PubMed ID: 22517167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
    Lin HL; Zhang GC; Huang YT; Lin SY
    J Pharm Sci; 2014 Aug; 103(8):2386-95. PubMed ID: 24942554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular self-assembly and perfected
    Yu YM; Niu YY; Wang LY; Li YT; Wu ZY; Yan CW
    Analyst; 2021 Apr; 146(8):2506-2519. PubMed ID: 33899060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
    Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells.
    Matai I; Sachdev A; Gopinath P
    Biomater Sci; 2015 Mar; 3(3):457-68. PubMed ID: 26222289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance.
    Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS
    J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
    Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
    J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
    Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
    Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.